Quarterly Balance Sheet

Noile-Immune Biotech Inc. - Filing #7338555

Concept As at
2024-03-31
As at
2023-12-31
Quarterly balance sheet
Balance sheet
Assets
Current assets
Cash and deposits
5,240,477,000 JPY
5,555,691,000 JPY
Other
3,875,000 JPY
5,561,000 JPY
Current assets
5,395,556,000 JPY
5,717,089,000 JPY
Non-current assets
Investments and other assets
61,436,000 JPY
61,857,000 JPY
Investments and other assets
Long-term prepaid expenses
2,268,000 JPY
2,699,000 JPY
Non-current assets
61,436,000 JPY
61,857,000 JPY
Assets
5,456,992,000 JPY
5,778,946,000 JPY
Liabilities
Current liabilities
Income taxes payable
11,199,000 JPY
30,210,000 JPY
Current liabilities
101,983,000 JPY
86,260,000 JPY
Non-current liabilities
Asset retirement obligations
5,233,000 JPY
5,233,000 JPY
Non-current liabilities
5,233,000 JPY
5,233,000 JPY
Liabilities
107,217,000 JPY
91,494,000 JPY
Net assets
Shareholders' equity
Share capital
4,047,254,000 JPY
4,045,977,000 JPY
Capital surplus
4,025,098,000 JPY
4,023,821,000 JPY
Retained earnings
-2,729,424,000 JPY
-2,389,247,000 JPY
Shareholders' equity
5,342,927,000 JPY
5,680,550,000 JPY
Share acquisition rights
6,847,000 JPY
6,901,000 JPY
Net assets
5,349,775,000 JPY
5,687,452,000 JPY
Liabilities and net assets
5,456,992,000 JPY
5,778,946,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.